Citations

Showing 10 of 108135 citations.

Do all outpatient spine surgeries cost the same? Comparison of economic outcomes data from a state-level database for outpatient lumbar decompression performed in an ambulatory surgery center or hospital outpatient setting
Alvi, Mohammed Ali , Wahood, Waseem , Kurian, Shyam J. , Zreik, Jad, Jeffery, Molly M. , Naessens, James M. , Spinner, Robert J. , Bydon, Mohamad , Jeffery, Molly Moore , Alvi, Mohammed Ali

Mayo Clinic

Journal of Neurosurgery: Spine | September 3, 2021 | Volume: 35 | Issue: 6 | Pages: 787-795

10.3171/2021.2.spine201820 | PMID 34416720 Get It

OBJECTIVE Spinal procedures are increasingly conducted as outpatient procedures, with a growing proportion conducted in ambulatory surgery centers (ASCs). To date, studies reporting outcomes and cost analyses for outpatient spinal procedures in the US have not distinguished the various outpatient settings from each other. In this study, the authors used a state-level administrative database to compare rates of overnight stays and nonroutine discharges as well as index admission charges and cumulative 7-, 30-, and 90-day charges for patients undergoing outpatient lumbar decompression in freestanding ASCs and hospital outpatient (HO) settings. METHODS For this project, the authors used the Florida State Ambulatory Surgery Database (SASD), offered by the Healthcare Cost and Utilization Project (HCUP), for the years 2013 and 2014. Patients undergoing outpatient lumbar decompression for degenerative diseases were identified using CPT (Current Procedural Terminology) and ICD-9 codes. Outcomes of interest included rates of overnight stays, rate of nonroutine discharges, index admission charges, and subsequent admission cumulative charges at 7, 30, and 90 days. Multivariable analysis was performed to assess the impact of outpatient type on index admission charges. Marginal effect analysis was employed to study the difference in predicted dollar margins between ASCs and HOs for each insurance type. RESULTS A total of 25,486 patients were identified; of these, 7067 patients (27.7%) underwent lumbar decompression in a freestanding ASC and 18,419 (72.3%) in an HO. No patient in the ASC group required an overnight stay compared to 9.2% (n = 1691) in the HO group (p < 0.001). No clinically significant difference in the rate of nonroutine discharge was observed between the two groups. The mean index admission charge for the ASC group was found to be significantly higher than that for the HO group ($35,017.28 ± $14,335.60 vs $33,881.50 ± $15,023.70; p < 0.001). Patients in ASCs were also found to have higher mean 7-day (p < 0.001), 30-day (p < 0.001), and 90-day (p = 0.001) readmission charges. ASC procedures were associated with increased charges compared to HO procedures for patients on Medicare or Medicaid (mean index admission charge increase $4049.27, 95% CI $2577.87–$5520.67, p < 0.001) and for patients on private insurance ($4775.72, 95% CI $4171.06–$5380.38, p < 0.001). For patients on self-pay or no charge, a lumbar decompression procedure at an ASC was associated with a decrease in index admission charge of −$10,995.38 (95% CI −$12124.76 to −$9866.01, p < 0.001) compared to a lumbar decompression procedure at an HO. CONCLUSIONS These “real-world” results from an all-payer statewide database indicate that for outpatient spine surgery, ASCs may be associated with higher index admission and subsequent 7-, 30-, and 90-day charges. Given that ASCs are touted to have lower overall costs for patients and better profit margins for physicians, these analyses warrant further investigation into whether this cost benefit is applicable to outpatient spine procedures.
A multicenter analysis of the prognostic value of histone H3 K27M mutation in adult high-grade spinal glioma
Moniz‐Garcia, Diogo , Higgins, Dominique , Vivas-Buitrago, Tito , Jentoft, Mark E. , Solomon, David A. , Pennington, Zach , Sherman, Wendy, Delgardo, Mychael, Bydon, Mohamad , Kalani, Maziyar A. , Zanazzi, George , Tsankova, Nadejda M. , McCormick, Paul C., Sciubba, Daniel M. , Lo, Sheng-Fu Larry , Clarke, Jennifer , Quiñones‐Hinojosa, Alfredo , Garcia, Diogo P, Jentoft, Mark, Solomon, David A , Pennington, Zach , Garcia, Diogo Moniz , Tsankova, Nadejda M , Akinduro, Oluwaseun O. , Daniels, David J. , Bendok, Bernard R. , Abode-Iyamah, Kingsley

Mayo Clinic

Journal of Neurosurgery: Spine | September 3, 2021 | Volume: 35 | Issue: 6 | Pages: 834-843

10.3171/2021.2.spine201675 | PMID 34416733 Get It

OBJECTIVE High-grade spinal glioma (HGSG) is a rare but aggressive tumor that occurs in both adults and children. Histone H3 K27M mutation correlates with poor prognosis in children with diffuse midline glioma. However, the role of H3 K27M mutation in the prognosis of adults with HGSG remains unclear owing to the rarity of this mutation, conflicting reports, and the absence of multicenter studies on this topic. METHODS The authors studied a cohort of 30 adult patients with diffuse HGSG who underwent histological confirmation of diagnosis, surgical intervention, and treatment between January 2000 and July 2020 at six tertiary academic centers. The primary outcome was the effect of H3 K27M mutation status on progression-free survival (PFS) and overall survival (OS). RESULTS Thirty patients (18 males and 12 females) with a median (range) age of 50.5 (19–76) years were included in the analysis. Eighteen patients had H3 K27M mutation–positive tumors, and 12 had H3 K27M mutation–negative tumors. The median (interquartile range) PFS was 3 (10) months, and the median (interquartile range) OS was 9 (23) months. The factors associated with increased survival were treatment with concurrent chemotherapy/radiation (p = 0.006 for PFS, and p ≤ 0.001 for OS) and American Spinal Injury Association grade C or better at presentation (p = 0.043 for PFS, and p < 0.001 for OS). There were no significant differences in outcomes based on tumor location, extent of resection, sex, or H3 K27M mutation status. Analysis restricted to HGSG containing necrosis and/or microvascular proliferation (WHO grade IV histological features) revealed increased OS for patients with H3 K27M mutation–positive tumors (p = 0.017). CONCLUSIONS Although H3 K27M mutant–positive HGSG was associated with poor outcomes in adult patients, the outcomes of patients with H3 K27M mutant–positive HGSG were somewhat more favorable compared with those of their H3 K27M mutant–negative HGSG counterparts. Further preclinical animal studies and larger clinical studies are needed to further understand the age-dependent effects of H3 K27M mutation.
Superficial siderosis associated with an iatrogenic posterior fossa dural leak identified on CT cisternography
Madhavan, Ajay A. , Wood, Christopher P. , Aksamit, Allen J. , Schwartz, Kara M., Atkinson, John L. D., Kumar, Neeraj , Atkinson, John L., Madhavan, Ajay A

Mayo Clinic

The Neuroradiology Journal | September 3, 2021 | Volume: 35 | Issue: 3 | Pages: 403-407

10.1177/19714009211042875 | PMID 34477007 Get It

Superficial siderosis refers to hemosiderin deposition along the pial surface of the brain and spinal cord. It results from chronic and repetitive low-grade bleeding into the subarachnoid space. Dural tears are a common cause of superficial siderosis. Although such tears typically occur in the spine, dural tears can also occur in the posterior fossa. In many cases, posterior fossa dural tears are iatrogenic, and patients may present with neuroimaging evidence of postoperative pseudomeningoceles. We present a case of superficial siderosis caused by a persistent posterior fossa dural leak. The patient presented with superficial siderosis 30 years after a Chiari I malformation repair. A pinhole-sized dural tear was identified preoperatively using computed tomography cisternography. The dural defect was successfully repaired. An additional small tear that was not seen on imaging was also identified at surgery and successfully repaired.
Stereotactic radiosurgery for secretory pituitary adenomas: systematic review and International Stereotactic Radiosurgery Society practice recommendations
Mathieu, David, Kotecha, Rupesh, Sahgal, Arjun, Salles, Antonio De, Fariselli, Laura, Pollock, Bruce E., Levivier, Marc, Ma, Lijun, Paddick, Ian, Regis, Jean, Yomo, Shoji, Suh, John H., Rubens, Muni, Sheehan, Jason P., Mathieu, David , Rubens, Muni , Yomo, Shoji , Mathieu, David , Kotecha, Rupesh, Sahgal, Arjun, Salles, Antonio De, Fariselli, Laura, Pollock, Bruce E., Levivier, Marc, Ma, Lijun, Paddick, Ian, Regis, Jean, Suh, John H., Sheehan, Jason P.

Mayo Clinic

Journal of Neurosurgery | September 3, 2021 | Volume: 136 | Issue: 3 | Pages: 801-812

10.3171/2021.2.jns204440 | PMID 34479203 Get It

OBJECTIVE A systematic review was performed to provide objective evidence on the use of stereotactic radiosurgery (SRS) in the management of secretory pituitary adenomas and develop consensus recommendations. METHODS The authors performed a systematic review of the English-language literature up until June 2018 using the PRISMA guidelines. The PubMed (Medline), Embase, and Cochrane databases were searched. A total of 45 articles reporting single-institution outcomes of SRS for acromegaly, Cushing’s disease, and prolactinomas were selected and included in the analysis. RESULTS For acromegaly, random effects meta-analysis estimates for crude tumor control rate, crude endocrine remission rate, and any new hypopituitarism rates were 97.0% (95% CI 96.0%–98.0%), 44.0% (95% CI 35.0%–53.0%), and 17.0% (95% CI 13.0%–23.0%), respectively. For Cushing’s disease, random effects estimates for crude tumor control rate, crude endocrine remission rate, and any new hypopituitarism rate were 92.0% (95% CI 87.0%–95.0%), 48.0% (95% CI 35.0%–61.0%), and 21.0% (95% CI 13.0%–31.0%), respectively. For prolactinomas, random effects estimates for crude tumor control rate, crude endocrine remission rate, and any new hypopituitarism rate were 93.0% (95% CI 90.0%–95.0%), 28.0% (95% CI 19.0%–39.0%), and 12.0% (95% CI 6.0%–24.0%), respectively. Meta-regression analysis did not show a statistically significant association between mean margin dose with crude endocrine remission rate or mean margin dose with development of any new hypopituitarism rate for any of the secretory subtypes. CONCLUSIONS SRS offers effective tumor control of hormone-producing pituitary adenomas in the majority of patients but a lower rate of endocrine improvement or remission.
Application of V̇o 2 to the Critical Power Model to Derive the Critical V̇o 2
Succi, Pasquale J. , Dinyer, Taylor K. , Byrd, M. Travis, Voskuil, Caleb C. , Bergstrom, Haley C.

Mayo Clinic

Journal of Strength & Conditioning Research | September 3, 2021 | Volume: 36 | Issue: 12 | Pages: 3374-3380

10.1519/jsc.0000000000004134 | PMID 34474433 Get It

Abstract Succi, PJ, Dinyer, TK, Byrd, MT, Voskuil, CC, and Bergstrom, HC. Application of V̇ o 2 to the critical power model to derive the critical V̇ o 2 . J Strength Cond Res 36(12): 3374–3380, 2022—The purposes of this study were to (a) determine whether the critical power (CP) model could be applied to V̇ o 2 to estimate the critical V̇ o 2 (CV̇ o 2 ) and (b) to compare the CV̇ o 2 with the V̇ o 2 at CP (V̇ o 2 CP), the ventilatory threshold (VT), respiratory compensation point (RCP), and the CV̇ o 2 without the V̇ o 2 slow component (CV̇ o 2 slow). Nine subjects performed a graded exercise test to exhaustion to determine V̇ o 2 peak, VT, and RCP. The subjects performed 4 randomized, constant power output work bouts to exhaustion. The time to exhaustion (T Lim ), the total work (W Lim ), and the total volume of oxygen consumed with (TV̇ o 2 ) and without the slow component (TV̇ o 2 slow) were recorded during each trial. The linear regressions of the TV̇ o 2 vs. T Lim , TV̇ o 2 slow vs. T Lim , and W Lim vs. T Lim relationship were performed to derive the CV̇ o 2 , CV̇ o 2 slow, and CP, respectively. A 1-way repeated-measures analysis of variance ( p ≤ 0.05) with follow-up Sidak-Bonferroni corrected pairwise comparisons indicated that CV̇ o 2 (42.49 ± 3.22 ml·kg −1 ·min −1 ) was greater than VT (30.80 ± 4.66 ml·kg −1 ·min −1 ; p < 0.001), RCP (36.74 ± 4.49 ml·kg −1 ·min −1 ; p = 0.001), V̇ o 2 CP (36.76 ± 4.31 ml·kg −1 ·min −1 ; p < 0.001), and CV̇ o 2 slow (38.26 ± 2.43 ml·kg −1 ·min −1 ; p < 0.001). However, CV̇ o 2 slow was not different than V̇ o 2 CP ( p = 0.140) or RCP ( p = 0.235). Thus, the CP model can be applied to V̇ o 2 to derive the CV̇ o 2 and theoretically is the highest metabolic steady state that can be maintained for an extended period without fatigue. Furthermore, the ability of the CV̇ o 2 to quantify the metabolic cost of exercise and the inefficiency associated with the V̇ o 2 slow component may provide a valuable tool for researchers and coaches to examine endurance exercise.
Longitudinal scoliosis behavior in Chiari malformation with and without syringomyelia
Chotai, Silky , Nadel, Jeffrey , Holste, Katherine G. , Mossner, James M. , Smith, Brandon W. , Kapurch, Joseph, Muraszko, Karin M. , Garton, Hugh , Maher, Cormac O. , Strahle, Jennifer M. , Kapurch, Joseph R

Mayo Clinic

Journal of Neurosurgery: Pediatrics | September 3, 2021 | Volume: 28 | Issue: 5 | Pages: 585-591

10.3171/2021.5.peds20915 | PMID 34479199 Get It

OBJECTIVE The objective of this study was to understand the natural history of scoliosis in patients with Chiari malformation type I (CM-I) with and without syringomyelia. METHODS A retrospective review of data was conducted. Patients with CM-I were identified from a cohort of 14,118 individuals age 18 years or younger who had undergone MRI over an 11-year period at the University of Michigan. Patients eligible for study inclusion had a coronal curve ≥ 10° on radiography, associated CM-I with or without syringomyelia, and at least 1 year of clinical follow-up prior to any surgery. Curve magnitude at initial diagnosis, prior to posterior fossa decompression (PFD; if applicable), and at the last follow-up (prior to any surgical correction of scoliosis) was recorded, and clinical and radiographic characteristics were noted. The change in curve magnitude by 10° was defined as curve progression (increase by 10°) or regression (decrease by 10°). RESULTS Forty-three patients met the study inclusion criteria and were analyzed. About one-third (35%) of the patients presented with symptoms attributed to their CM-I. The mean degree of scoliosis at presentation was 32.6° ± 17.7°. Twenty-one patients (49%) had an associated syrinx. The mean tonsil position below the level of the foramen magnum was 9.8 ± 5.8 mm. Patients with a syrinx were more likely to have a curve > 20° (86% vs 41%, p = 0.002). Curve magnitude remained stable (≤ ±10°) in 77% of patients (33/43), progressed in 16% (7/43), and regressed in 7% (3/43). Mean age was higher (14.8 ± 0.59 years) among patients with regressed curves (p = 0.026). All regressed curves initially measured ≤ 20° (mean 14° ± 5.3°), and none of the patients with regressed curves had a syrinx. The change in curve magnitude was statistically similar in patients with (7.32° ± 17.7°) and without (5.32° ± 15.8°) a syrinx (p = 0.67). After a mean follow-up of 3.13 ± 2.04 years prior to surgery, 27 patients (63%) ultimately underwent posterior fossa or scoliosis correction surgery. For those who eventually underwent PFD only, the rate of change in curve magnitude prior to surgery was 0.054° ± 0.79°. The rate of change in curve magnitude was statistically similar before (0.054° ± 0.79°) and after (0.042° ± 0.33°) surgery (p = 0.45) for patients who underwent PFD surgery only. CONCLUSIONS The natural history of scoliosis in the presence of CM-I is variable, though most curves remained stable. All curves that regressed were ≤ 20° at initial diagnosis, and most patients in such cases were older at scoliosis diagnosis. Patients who underwent no surgery or PFD only had similar profiles for the change in curve magnitude, which remained relatively stable overall, as compared to patients who underwent PFD and subsequent fusion, who demonstrated curve progression. Among the patients with a syrinx, no curves regressed, most remained stable, and some progressed. Understanding this variability is a first step toward building a prediction model for outcomes for these patients.
Cyclosporiasis—Updates on Clinical Presentation, Pathology, Clinical Diagnosis, and Treatment
Mathison, Blaine A. , Pritt, Bobbi S. , Pritt, Bobbi S , Mathison, Blaine A

Mayo Clinic

Microorganisms | September 2, 2021 | Volume: 9 | Issue: 9 | Pages: 1863

10.3390/microorganisms9091863 | PMID 34576758 Get It

Cyclospora cayetanensis is an intestinal coccidian parasite transmitted to humans through the consumption of oocysts in fecally contaminated food and water. Infection is found worldwide and is highly endemic in tropical and subtropical regions with poor sanitation. Disease in developed countries is usually observed in travelers and in seasonal outbreaks associated with imported produce from endemic areas. Recently, summertime outbreaks in the United States have also been linked to locally grown produce. Cyclosporiasis causes a diarrheal illness which may be severe in infants, the elderly, and immunocompromised individuals. The increased adoption of highly sensitive molecular diagnostic tests, including commercially available multiplex panels for gastrointestinal pathogens, has facilitated the detection of infection and likely contributed to the increased reports of cases in developed countries. This manuscript reviews important aspects of the biology, epidemiology, and clinical manifestations of C. cayetanensis and provides an in-depth discussion of current laboratory diagnostic methods.
Body Mass Index and In-Hospital Management and Outcomes of Acute Myocardial Infarction
Patlolla, Sri Harsha , Gurumurthy, Gayathri , Sundaragiri, Pranathi R., Cheungpasitporn, Wisit , Vallabhajosyula, Saraschandra , Cheungpasitporn, Wisit , Vallabhajosyula, Saraschandra , Harsha Patlolla, Sri

Mayo Clinic

Medicina | September 2, 2021 | Volume: 57 | Issue: 9 | Pages: 926

10.3390/medicina57090926 | PMID 34577849 Get It

Background and Objectives: Contemporary data on the prevalence, management and outcomes of acute myocardial infarction (AMI) in relation to body mass index (BMI) are limited. Materials and Methods: Using the National Inpatient Sample from 2008 through 2017, we identified adult AMI hospitalizations and categorized them into underweight (BMI < 19.9 kg/m2), normal BMI and overweight/obese (BMI > 24.9 kg/m2) groups. We evaluated in-hospital mortality, utilization of cardiac procedures and resource utilization among these groups. Results: Among 6,089,979 admissions for AMI, 38,070 (0.6%) were underweight, 5,094,721 (83.7%) had normal BMI, and 957,188 (15.7%) were overweight or obese. Over the study period, an increase in the prevalence of AMI was observed in underweight and overweight/obese admissions. Underweight AMI admissions were, on average, older, with higher comorbidity, whereas overweight/obese admissions were younger and had lower comorbidity. In comparison to the normal BMI and overweight/obese categories, significantly lower use of coronary angiography (62.3% vs. 74.6% vs. 37.9%) and PCI (40.8% vs. 47.7% vs. 19.6%) was observed in underweight admissions (all p < 0.001). The underweight category was associated with significantly higher in-hospital mortality (10.0% vs. 5.5%; OR 1.23 (95% CI 1.18–1.27), p < 0.001), whereas being overweight/obese was associated with significantly lower in-hospital mortality compared to normal BMI admissions (3.1% vs. 5.5%; OR 0.73 (95% CI 0.72–0.74), p < 0.001). Underweight AMI admissions had longer lengths of in-hospital stay with frequent discharges to skilled nursing facilities, while overweight/obese admissions had higher hospitalization costs. Conclusions: In-hospital management and outcomes of AMI vary by BMI. Underweight status was associated with worse outcomes, whereas the obesity paradox was apparent, with better outcomes for overweight/obese admissions.
Utilization of a Colorectal Cancer Screening Test Among Individuals With Average Risk
Fisher, Deborah A. , Miller‐Wilson, Lesley‐Ann , Wilson, Kathleen , Limburg, Paul, Princic, Nicole , Fendrick, A. Mark , Limburg, Paul J.

Mayo Clinic

JAMA Network Open | September 2, 2021 | Volume: 4 | Issue: 9 | Pages: e2122269

10.1001/jamanetworkopen.2021.22269 | PMID 34473259 Get It